跳至主要内容
临床试验/RBR-9n7kfw
RBR-9n7kfw进行中(未招募)未知

Efficacy of Lactobacillus acidophilus eBifidobacterium lactis on Nonalcoholic Fatty Liver Disease and insulin resistance in obese adolescents: A randomized clinical trial

Escola Bahiana de Medicina e Saúde Pública0 个研究点开始时间: 2020年9月30日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
10Y 至 19Y(—)

入选标准

  • Adolescents between 10 to 19 years old; Diagnosis of obesity, based on the BMI/age indicator above +2 z scores of the WHO reference curve; Previous ultrasound diagnosis of Non-Alcoholic Fatty Liver Disease; Signature of the Review Board Authorization Form; Previous history of attendance to the service (absence of absences in the previous year); Absence of diabetes mellitus (fasting blood glucose below 100 mg/dl); Living in Salvador or metropolitan urban area;

排除标准

  • Presence of endogenous obesity; Presence of psychiatric comorbidity or disease that interferes with weight evolution; Use of medications such as metformin, statins, laxatives, antibiotics, antidepressants, corticosteroids, anxiolytics and / or any other medication that may interfere with the gut microbiota; Be classified as SGA (Small for Gestational Age) at birth;

研究者

发起方
Escola Bahiana de Medicina e Saúde Pública

相似试验